Matritech (NASDAQ - NMPS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Matritech (NASDAQ - NMPS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: R Sandvig who wrote (512)	12/8/1997 5:10:00 PM
From: William J. Leiby	Read Replies (1) of 849

Hi: Not sure about the context in your use of "hyberbole". You mean hype within their news release or outside hype surrounding a news release? Whatever the case I think investors are waiting to see what Bayer will do. Also note this latest news release was preclinical findings. I think also the jury may be out on Matritech's management with respect to how well they can execute marketing and sales plans. Their science appears wonderful but will management be able to turn it into profits assuming they eventually get FDA approval from any one of the diagnostic tests now in the pipeline? Regards, Bill

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next